Adverum Biotechnologies, Inc. (ADVM) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 28.91M | 48.39M | 89.47M | 131.3M | 161.08M | 179.42M | 199.13M | 102.77M | 124.6M | 147.14M | 168.87M | 190.59M |
| Cash & Short-Term Investments | 26.06M | 44.4M | 83.08M | 125.69M | 153.24M | 173.83M | 193.33M | 96.53M | 117.08M | 141.45M | 164.28M | 185.59M |
| Cash Only | 26.06M | 42.42M | 49.16M | 60.65M | 92.85M | 127.32M | 149.61M | 75M | 105.37M | 111.19M | 67.55M | 68.43M |
| Short-Term Investments | 0 | 1.98M | 33.92M | 65.04M | 60.39M | 46.51M | 43.72M | 21.53M | 11.72M | 30.27M | 96.73M | 117.16M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.85M | 3.99M | 6.39M | 5.61M | 7.84M | 5.59M | 5.8M | 6.25M | 7.51M | 5.69M | 4.59M | 5.01M |
| Total Non-Current Assets | 43.49M | 47.79M | 48.19M | 48.54M | 73.3M | 74.39M | 68.7M | 52.99M | 72.17M | 94.29M | 106.7M | 117.78M |
| Property, Plant & Equipment | 39.49M | 44.34M | 44.72M | 45.22M | 62.91M | 64.28M | 65.53M | 49.79M | 68.25M | 90.33M | 102.85M | 113.86M |
| Fixed Asset Turnover | - | - | - | - | 0.02x | - | - | - | - | - | 0.04x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.98M | 0 | 0 | 0 | 9.09M | 0 | 0 | 0 | 0 | 2.65M | 0 | 2.5M |
| Other Non-Current Assets | 2.02M | 3.45M | 3.47M | 3.32M | 1.29M | 10.1M | 3.17M | 3.21M | 3.92M | 1.31M | 3.85M | 1.41M |
| Total Assets | 72.4M | 96.18M | 137.65M | 179.84M | 234.38M | 253.8M | 267.83M | 155.77M | 196.77M | 241.43M | 275.58M | 308.37M |
| Asset Turnover | - | - | - | - | 0.00x | - | - | - | - | - | 0.01x | - |
| Asset Growth % | -69.11% | -62.1% | -48.6% | 15.45% | 19.11% | 5.13% | -2.81% | -49.49% | -40.8% | -35.61% | -32.36% | -29.87% |
| Total Current Liabilities | 44.75M | 31.36M | 25.09M | 22.9M | 27.66M | 22.46M | 21.55M | 19.98M | 28.86M | 44.52M | 46.47M | 32.25M |
| Accounts Payable | 12.46M | 4.75M | 1.82M | 1.61M | 2.11M | 1.97M | 1.9M | 1.92M | 2.17M | 1.42M | 2.86M | 2.24M |
| Days Payables Outstanding | 9.78K | - | - | - | - | - | - | - | - | - | 346.14 | - |
| Short-Term Debt | 5.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.4M | 0 | 13.24M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 16.66M | 8.14M | 6.15M | 5.96M | 8.51M | 5.96M | 5.08M | 8.77M | 8.94M | 10.84M | 7.84M | 7.8M |
| Current Ratio | 0.65x | 1.54x | 3.57x | 5.73x | 5.82x | 7.99x | 9.24x | 5.14x | 4.32x | 3.31x | 3.63x | 5.91x |
| Quick Ratio | 0.65x | 1.54x | 3.57x | 5.73x | 5.82x | 7.99x | 9.24x | 5.14x | 4.32x | 3.31x | 3.63x | 5.91x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 83.31M | 85.04M | 86.14M | 86.23M | 62.6M | 63.31M | 63.99M | 68.56M | 65.2M | 65.76M | 71.35M | 94.61M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 83.13M | 84.86M | 85.95M | 86.04M | 62.6M | 63.31M | 63.99M | 68.56M | 65.2M | 65.76M | 71.35M | 93.56M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 179K | 184K | 189K | 192K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.05M |
| Total Liabilities | 128.05M | 116.4M | 111.23M | 109.13M | 90.26M | 85.77M | 85.54M | 88.55M | 94.06M | 110.27M | 117.82M | 126.85M |
| Total Debt | 88.94M | 92.22M | 93.18M | 91.7M | 73.26M | 73.89M | 74.48M | 74.04M | 75.52M | 91.15M | 97.61M | 106.8M |
| Net Debt | 62.88M | 49.8M | 44.02M | 31.05M | -19.59M | -53.43M | -75.13M | -959K | -29.84M | -20.04M | 30.06M | 38.37M |
| Debt / Equity | - | - | 3.53x | 1.30x | 0.51x | 0.44x | 0.41x | 1.10x | 0.74x | 0.69x | 0.62x | 0.59x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | -21.80x | - | - | - | -0.42x |
| Total Equity | -55.65M | -20.22M | 26.42M | 70.71M | 144.12M | 168.03M | 182.29M | 67.22M | 102.71M | 131.16M | 157.76M | 181.52M |
| Equity Growth % | -138.62% | -112.03% | -85.51% | 5.19% | 40.31% | 28.11% | 15.55% | -62.97% | -50.7% | -46.27% | -44.25% | -42.59% |
| Book Value per Share | -2.37 | -0.96 | 1.26 | 3.38 | 6.90 | 8.06 | 11.06 | 1.16 | 1.77 | 2.26 | 2.72 | 3.13 |
| Total Shareholders' Equity | -55.65M | -20.22M | 26.42M | 70.71M | 144.12M | 168.03M | 182.29M | 67.22M | 102.71M | 131.16M | 157.76M | 181.52M |
| Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 1K | 10K | 10K | 10K | 10K |
| Retained Earnings | -1.21B | -1.16B | -1.11B | -1.07B | -990.17M | -963.04M | -944.56M | -936.02M | -896.06M | -863.18M | -831.67M | -802.61M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -440K | -451K | -458K | -407K | -268K | -525K | -533K | -473K | -552K | -606K | -799K | -1.53M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |